New drug shows promise for rare Skin-Hardening disease
Disease control
Completed
This small study tested a drug called nemolizumab in 6 people with systemic sclerosis, a rare disease that causes skin to harden and tighten. The goal was to see if the drug could reduce skin thickness over 24 weeks and check for side effects. Results may help guide future resear…
Phase: PHASE2 • Sponsor: Maruho Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC